Surgery-First Versus Neoadjuvant Chemotherapy in Stage I (cT1c) Triple-Negative Breast Cancer: A Critical Reappraisal

Study limitation reported by the research below: “This paper's publication date (2026-09-12) is only 3 days before today's date — full indexing and peer-review confirmation details are not verifiable.”